E-LIB Suche - Ergebnisse für: Bugarski-Kirola, Dragana

1

Adherence to Background Antipsychotic and Pimavanserin in P..:

Bugarski-Kirola, Dragana ; Abbs, Brandon ; Odetalla, Ramzey...
Patient Preference and Adherence. 18 (2024) - p. 207-216 , 2024

Link: https://doi.org/10.2147/..

2

Conducting CNS trials during a public health emergency – Le..:

Olugemo, Kemi ; Bugarski-Kirola, Dragana ; Dawson, Gerard R....
Neuroscience Applied. 2 (2023) - p. 101129 , 2023

Link: https://doi.org/10.1016/..

3

Effects of adjunctive pimavanserin and current antipsychoti..:

Bugarski-Kirola, Dragana ; Nunez, Rene ; Odetalla, Ramzey..
Frontiers in Psychiatry. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

4

Pimavanserin Exposure-Response Analyses in Patients With Sc..:

Darwish, Mona ; Bugarski-Kirola, Dragana ; Passarell, Julie...
Journal of Clinical Psychopharmacology. 42 (2022) 6 - p. 544-551 , 2022

Link: https://doi.org/10.1097/..

5

ENHANCE: Phase 3, Randomized, Double-Blind, Placebo-Control..:

Bugarski-Kirola, Dragana ; Bitter, Istvan ; Liu, I-Yuan..
Schizophrenia Bulletin Open. 3 (2022) 1 - p. , 2022

Link: https://doi.org/10.1093/..

6

Comorbidities and behavioral issues:

Bugarski-Kirola, Dragana ; Marcus, Ronald N
European Neuropsychopharmacology. , 2021

Link: https://doi.org/10.1016/..

7

T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHAN..:

Stankovic, Srdjan ; (Cathy) Liu, I-Yuan ; Feldman, Peter D...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S247-S247 , 2020

Link: https://doi.org/10.1093/..

8

T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE..:

Stankovic, Srdjan ; Darwish, Mona ; (Cathy) Liu, I-Yuan..
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S247-S248 , 2020

Link: https://doi.org/10.1093/..

9

Bitopertin in Negative Symptoms of Schizophrenia—Results Fr..:

Bugarski-Kirola, Dragana ; Blaettler, Thomas ; Arango, Celso...
Biological Psychiatry. 82 (2017) 1 - p. 8-16 , 2017

Link: https://doi.org/10.1016/..

10

Defining therapeutic benefit for people with schizophrenia:..:

Schooler, Nina R. ; Buchanan, Robert W. ; Laughren, Thomas...
Schizophrenia Research. 162 (2015) 1-3 - p. 169-174 , 2015

Link: https://doi.org/10.1016/..

11

Report on ISCTM Consensus Meeting on Clinical Assessment of..:

Keefe, Richard S. E. ; Haig, George M. ; Marder, Stephen R....
Schizophrenia Bulletin. , 2015

Link: https://doi.org/10.1093/..

12

Psychometric evaluation of the Work Readiness Questionnaire..:

Potkin, Steven G. ; Bugarski-Kirola, Dragana ; Edgar, Chris J....
CNS Spectrums. 21 (2014) 2 - p. 199-206 , 2014

Link: https://doi.org/10.1017/..

13

Validity and utility of the PANSS negative symptoms factor ..:

Edgar, Chris J. ; Blaettler, Thomas ; Bugarski-Kirola, Dragana...
Schizophrenia Research. 158 (2014) 1-3 - p. e4 , 2014

Link: https://doi.org/10.1016/..

14

Efficacy and safety of adjunctive bitopertin (5 and 10mg) v..:

Arango, Celso ; Nasrallah, Henry ; Lawrie, Stephen...
Schizophrenia Research. 158 (2014) 1-3 - p. e1 , 2014

Link: https://doi.org/10.1016/..

15

Efficacy and safety of adjunctive bitopertin (10 and 20mg) ..:

Blaettler, Thomas ; Bugarski-Kirola, Dragana ; Fleischhacker, W. Wolfgang...
Schizophrenia Research. 158 (2014) 1-3 - p. e2-e3 , 2014

Link: https://doi.org/10.1016/..